GSK, Medicago get Health Canada nod for COVIFENZ MD Bureau27 Feb 2022 11:00 AM ISTNew Delhi: Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) have recently announced that Health Canada...
Moderna, Thermo Fisher Scientific expands collaboration for mRNA medicines MD Bureau27 Feb 2022 10:00 AM ISTNew Delhi: Moderna, Inc. and Thermo Fisher Scientific Inc. have announced a 15-year strategic collaboration agreement to enable dedicated...
Coronavirus vaccine sales push Moderna to USD 12 billion profit in 2021 MD Bureau26 Feb 2022 3:47 PM ISTWashington: Moderna's COVID-19 vaccine brought in nearly USD 7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase...
GSK, Sanofi to seek regulatory authorization for COVID vaccine MD Bureau24 Feb 2022 11:00 AM ISTParis: Sanofi and GSK have announced that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory...
Pfizer COVID vaccine approved in South Korea for 5-11 years old MD Bureau24 Feb 2022 10:00 AM ISTThe vaccine will help protect younger children from infections or serious illness amid South Korea's fast-developing omicron surge, the MDFS added.
South Korean company to develop combined vaccine for COVID, influenza MD Bureau23 Feb 2022 1:14 PM ISTSeoul: As 'flurona,' which means having both COVID-19 and influenza at the same time, is recently popping up in many countries, including Israel,...
Panacea Biotec, CEPI, THSTI partner to develop broadly protective Betacoronavirus vaccines MD Bureau23 Feb 2022 10:00 AM ISTNew Delhi: Panacea Biotec has recently announced a partnership with the Translational Health Science and Technology Institute (THSTI) and...
Biological E Corbevax gets DCGI nod for 12-18 years Ruchika Sharma22 Feb 2022 12:22 PM ISTThe CORBEVAX vaccine is administered through intramuscular route with two doses scheduled 28 days apart.
US FDA considers approving a second Covid-19 booster shot: Report MD Bureau21 Feb 2022 9:00 AM ISTNew Delhi: US health regulators are looking at authorizing a potential fourth dose of a Covid-19 vaccine in the fall, the Wall Street Journal reported...
GSK halts respiratory virus vaccine trial in pregnant women Ruchika Sharma19 Feb 2022 2:16 PM ISTLondon: GSK has paused a late-stage trial of its vaccine candidate against the respiratory syncytial virus (RSV) in pregnant women based on safety...
Moderna to develop mRNA-based vaccine for shingles Ruchika Sharma19 Feb 2022 12:41 PM ISTModerna's shingles vaccine is being developed to target the varicella-zoster virus.
Novavax COVID vaccine gets nod in Canada Ruchika Sharma18 Feb 2022 1:02 PM ISTGaithersburg: Novavax, Inc. has recently announced that Health Canada has granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,...
